- Home
- TER vs NBIX Comparison
TER vs NBIX Comparison
Compare TER & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TER | NBIX |
|---|---|---|
| Founded | 1960 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 14.4B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | TER | NBIX |
|---|---|---|
| Price | $200.33 | $155.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 19 |
| Target Price | $161.85 | ★ $173.79 |
| AVG Volume (30 Days) | ★ 3.4M | 969.9K |
| Earning Date | 10-28-2025 | 10-28-2025 |
| Dividend Yield | ★ 0.24% | N/A |
| EPS Growth | N/A | ★ 12.44 |
| EPS | 2.75 | ★ 4.19 |
| Revenue | ★ $2,859,571,000.00 | $2,682,700,000.00 |
| Revenue This Year | $9.79 | $23.76 |
| Revenue Next Year | $22.74 | $18.01 |
| P/E Ratio | $72.91 | ★ $37.10 |
| Revenue Growth | 4.46 | ★ 19.61 |
| 52 Week Low | $65.77 | $84.23 |
| 52 Week High | $203.12 | $157.67 |
Technical Indicators
Market Signals| Indicator | TER | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 71.05 | 64.81 |
| Support Level | $178.04 | $150.26 |
| Resistance Level | $173.83 | $154.35 |
| Average True Range (ATR) | 7.80 | 4.16 |
| MACD | 2.38 | 1.07 |
| Stochastic Oscillator | 95.88 | 93.25 |
Price Performance
Historical ComparisonAbout TER Teradyne Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.